Create your Personal Health Record and unlock support built around you

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Video

BETA - Can individuals on dialysis consider transplant?

Posted by
HealthTree Logo HealthTree
• September 23, 2024

Description

Learn wether or not patients on dialysis should consider transplant with HealthTree University cancer specialists

On this video

Transcript

Can individuals on dialysis consider transplant as an option? It is very common to have kidney issues. The majority aren't on dialysis, but it is definitely something that can be caused by the myeloma-derived proteins and light chains. For example, those light chains made by the myeloma cells can deposit in the kidneys. They can cause light chain cast nephropathy. They can form amyloid deposits. They can cause light chain deposition disease. There are several mechanisms where myeloma can cause kidney failure. And also these patients are typically in their 60s and have hypertension, diabetes, all kinds of other reasons for chronic kidney disease at baseline. And so then this might tip them over the edge and cause them to end up needing dialysis. If we catch that early enough and get them on treatment quickly, roughly a quarter of these patients at least might be able to come off dialysis with effective treatment of the myeloma. But certainly the longer they've been on dialysis or the longer it's been, the less likely we'll be able to get them off dialysis. Can patients on dialysis go through a stem cell transplant? Yes, they can. We do it routinely, especially if they're going through transplant for multiple myeloma, which involves just high dose of Malfalan chemotherapy. What we typically do is we'll reduce the dose and we'll split it over two days and minimize the toxicity that way. So that way those patients that are on dialysis can safely go through the stem cell transplant. It may be different for other diseases where they have different induction regimens. It may be more difficult, for example, for lymphoma patients on dialysis that have a different conditioning regimen. But for myeloma, we routinely do it and it's very feasible. So what we typically do is we'll have them get their dialysis before they come in. They'll get the two days of Malfalan after the dialysis and then the next day they'll have the next dialysis in the hospital or in the outpatient, so the day after the chemo once it's already out of their system anyway. There's probably not a lot of removal of Malfalan with dialysis anyway, but just to be on the safe side, we typically separate it and then we give them a day of rest, a couple days of rest to make sure it's all out of their system and then the next dialysis is usually early in the morning followed by the stem cell infusion after all the toxins are cleaned out of their blood at that point. If I do a lot of patient on dialysis, I actually have a lot of experience on dialysis. Here at Duke, I offer the dual approach where a patient on dialysis has difficulty with a myeloma because they're not candidates for clinical trials, they have less options. So I do the autologous transplant and then I actually do the kidney transplant. I collaborate with the renal transplant team and I send them for a kidney transplant with a lot of success stories, I have to say. So we offer that approach for patient on dialysis.

Related Content